Literature DB >> 26805554

Long non-coding RNAs expression profiles in hepatocytes of mice after hematopoietic stem cell transplantation.

Jianlin Qiao1,2,3, Haina Yao1,2, Yuan Xia1,2, Peipei Chu1,2, Mingfeng Li1,2, Yulu Wu1,2, Wen Li3, Lan Ding3, Kunming Qi3, Depeng Li3, Kailin Xu1,2,3, Lingyu Zeng1,2,3.   

Abstract

Hepatic veno-occlusive disease (HVOD), one serious complication following hematopoietic stem cell transplantation (HSCT), is mainly initiated by the damage to sinusoidal endothelial cells and hepatocytes. Long non-coding RNAs (lncRNAs) play an important role in the proliferation of hepatocytes and liver regeneration. lncRNAs profile in hepatocytes post-HSCT remains unclear. The aim of this study is to evaluate the profile of lncRNAs in hepatocytes of mice after HSCT. Mice HSCT model was established through infusion of 5 × 10(6) bone marrow mononuclear cells. On day 7, 14 and 33 after HSCT, mice were sacrificed for analysis of liver pathology, function and index. Total RNA was extracted from hepatocytes of mice on day 14 for microarray analysis of the expression profiles of lncRNAs by Arraystar Mouse lncRNA Microarray v2.0. Obvious edema and spotty necrosis of hepatocytes with inflammatory cells infiltration were observed post-HSCT. Meanwhile, increased levels of alkaline phosphatase, aspartate transaminase, and total bilirubin, as well as elevated liver index were also found. 2,918 up-regulated and 1,911 down-regulated lncRNAs in hepatocytes were identified. Some of differentially expressed mRNAs had adjacent lncRNAs that were also significantly dysregulated, with the same dysregulation direction. T-cell receptor (up-regulation) and VEGF signaling pathway (down-regulation) were identified as one of the most enriched pathways. Dysregulated lncRNAs might be involved in hepatocytes damage after HSCT, suggesting targeting them might be a novel approach in amelioration of hepatocytes damage.
© 2016 International Union of Biochemistry and Molecular Biology.

Entities:  

Keywords:  hematopoietic stem cell transplantation; hepatic veno-occlusive disease; hepatocyte; long non-coding RNAs

Mesh:

Substances:

Year:  2016        PMID: 26805554     DOI: 10.1002/iub.1479

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  5 in total

Review 1.  Long Non-Coding RNAs: A Novel Paradigm for Toxicology.

Authors:  Joseph L Dempsey; Julia Yue Cui
Journal:  Toxicol Sci       Date:  2016-11-17       Impact factor: 4.849

2.  LncRNA AFAP1-AS1 is a prognostic biomarker and serves as oncogenic role in retinoblastoma.

Authors:  Fengqin Hao; Yanan Mou; Laixia Zhang; Shuna Wang; Yang Yang
Journal:  Biosci Rep       Date:  2018-05-15       Impact factor: 3.840

3.  Role of the long non‑coding RNA‑Annexin A2 pseudogene 3/Annexin A2 signaling pathway in biliary atresia‑associated hepatic injury.

Authors:  Yeletai Nuerzhati; Rui Dong; Zai Song; Shan Zheng
Journal:  Int J Mol Med       Date:  2018-12-11       Impact factor: 4.101

4.  Long Non-coding RNAs and mRNAs Expression Profiles of Monocyte-Derived Dendritic Cells From PBMCs in AR.

Authors:  Yumei Zhou; Xuemei Chen; Yanfei Zheng; Rongmin Shen; Shuxian Sun; Fei Yang; Jiayu Min; Lei Bao; Yan Zhang; Xiaoshan Zhao; Ji Wang; Qi Wang
Journal:  Front Cell Dev Biol       Date:  2021-02-09

Review 5.  Potential Roles of Long Noncoding RNAs as Therapeutic Targets in Organ Transplantation.

Authors:  Saeedeh Salehi; Shima Afzali; Abbas Shahi; Ali Akbar Amirzargar; Yaser Mansoori
Journal:  Front Immunol       Date:  2022-03-11       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.